Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 17,340 SION shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Sionna Therapeutics, Inc. (SION) | Grant/Award | 17,340 | n/a |
| Jun 5, 2026 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 42,000 | n/a |
| Jun 5, 2026 | MBX Biosciences, Inc. (MBX) | Grant/Award | 12,500 | n/a |
| May 29, 2026 | Spyre Therapeutics, Inc. (SYRE) | Grant/Award | 8,026 | n/a |
| Jan 22, 2026 | MBX Biosciences, Inc. (MBX) | Grant/Award | 32,000 | n/a |
| Jun 16, 2025 | Sionna Therapeutics, Inc. (SION) | Grant/Award | 19,959 | n/a |
| Jun 9, 2025 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 33,500 | n/a |
| Jun 2, 2025 | Spyre Therapeutics, Inc. (SYRE) | Grant/Award | 25,000 | n/a |
| Jun 10, 2024 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 67,500 | n/a |
| May 16, 2024 | Spyre Therapeutics, Inc. (SYRE) | Grant/Award | 11,323 | n/a |